Comunicati Stampa
Salute e Benessere

Curetis Provides Update on Unyvero LRT FDA 510(k) Submission

Curetis / Curetis Provides Update on Unyvero LRT FDA 510(k) Submission . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.Curetis Provides Update on Unyvero LRT FDA510(k)Submission - Curetis reiterates...
Per maggiori informazioni
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili